Repertoire Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSG
Octave Specialty Group
OSG
|
+$13.3M |
| 2 |
Cable One
CABO
|
+$8.47M |
| 3 |
Sprinklr
CXM
|
+$6.92M |
| 4 |
Sotera Health
SHC
|
+$5.18M |
| 5 |
Tenet Healthcare
THC
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGI
Somnigroup International
SGI
|
+$10.5M |
| 2 |
Perimeter Solutions
PRM
|
+$10.2M |
| 3 |
Turning Point Brands
TPB
|
+$5.66M |
| 4 |
Dentsply Sirona
XRAY
|
+$3.53M |
| 5 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$2.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.71% |
| 2 | Communication Services | 1.91% |
| 3 | Materials | 1.78% |
| 4 | Industrials | 1.54% |
| 5 | Healthcare | 1.11% |
Similar funds
Repertoire Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Repertoire Partners held 67 positions worth $989M, up 253% from $280M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Repertoire Partners deployed $735M of net new capital in Q4 2022, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was Sotera Health: 693,832 shares worth $5.78M.
By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 14% a quarter earlier, followed by Communication Services and Materials.
On the sell side, the largest reduction was Somnigroup International, an estimated $10.5M trimmed.
- Repertoire Partners's largest Q4 2022 buy was Sotera Health: 693,832 shares worth $5.78M.
- Repertoire Partners added most to Octave Specialty Group in Q4 2022, an estimated $13.3M increase.
- Repertoire Partners's biggest Q4 2022 reduction was Somnigroup International, cutting an estimated $10.5M.
- Repertoire Partners fully exited Dentsply Sirona in Q4 2022, selling an estimated $3.53M.
- Repertoire Partners's ten largest holdings make up 94% of its $989M portfolio in Q4 2022.
- Repertoire Partners opened 12 new positions and closed 19 in Q4 2022.
- Repertoire Partners's portfolio value rose 253% quarter-over-quarter to $989M.
Based on Repertoire Partners's 13F filing for Q4 2022, filed 14 Feb 2023.